Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

On one wall of endocrinologist Kevan Herold’s office hangs artwork by a girl who joined one of his type 1 diabetes trials when she was 11 years old. The girl was diagnosed with stage 2 of the disease, ...

Vertex Pharmaceuticals’ CRISPR-based therapy made history as the first drug of its type, transforming care options for sickle ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's ...

Medical experts recognize type 5 diabetes as separate from other types, requiring specialized treatment focusing on ...

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin after the treatment. Research into the treatment is ongoing. Experts explain ...

Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin—a ...

Theres a clich in the type 1 diabetes community that a cure has been five years away for as long as anyone can remember. For decades, patients have been told that researchers were on the verge of a ...

Diabetes isn't curable because of the cells that produce insulin, the hormone key to helping the body break down blood sugar. These are the beta cells in the pancreas that either can't make enough ...

Hundreds of families and supporters are lacing up their shoes today for the annual Breakthrough T1D Walk at Liberty Memorial, ...

Treatment-induced neuropathy of diabetes (TIND) is a rare but potentially painful complication of diabetes caused by high blood sugar and nerve damage. Treatment-induced neuropathy of diabetes (TIND) ...